colorectal Cancer Screening in Bergamo: A success Story in Prevention
A new social impact report from ATS Bergamo details the impressive results of its colorectal cancer screening program, a vital initiative dedicated to combating one of the most common and serious cancers. Developed in alignment with Lombardy Region guidelines and the 2025 “system rules” (DGR no. XII/3720), the program showcases a commitment to clarity and public health.
This free screening program, available to Lombardy residents aged 50-74, is a collaborative effort between healthcare institutions, community providers, and local pharmacies. the report highlights the programS effectiveness in saving lives and offers citizens a clear understanding of its impact.
Key Achievements (2021-2024):
* Reach: Nearly 390,000 individuals were invited to participate, with invitation coverage increasing from 91% in 2021 to 98% in 2024 – exceeding regional targets.
* Participation: 55% of women and 51% of men completed the screening test. Follow-up colonoscopy rates after a positive test remained high, at 79-80%, among the best in Lombardy.
* Early Detection: Over 108,000 tests are performed annually, with a 4-5% positivity rate. Between 2021 and 2023, the program identified 264 carcinomas, over 1,000 high-risk adenomas, and approximately 3,000 low-risk lesions, preventing numerous cancer cases.
* Network: The program leverages a robust network including all pharmacies in the province and eight accredited public and private centers: Asst Papa Giovanni XXIII,Asst Bergamo Est e Ovest,Humanitas Gavazzeni,San Francesco nursing home,Palazzolo nursing home,San Pietro and San marco Polyclinic,alongside collaboration with general practitioners,community homes,and pharmacies.
Efficient Investment, Significant Return:
The program demonstrates strong financial efficiency. The average cost per participant is €11.60, and €6.23 per eligible citizen. In 2024, an investment of €1.05 million funded over 100,000 tests. This investment yields a substantial return, as early diagnosis can reduce mortality by up to 30% and enable less invasive treatment options.
“This Social Report is a tool for transparency and engagement,” states Nicoletta Castelli,Health Director of ATS Bergamo. “Sharing these results recognizes the dedication of our network and reinforces the importance of prevention as the cornerstone of healthcare.”
Looking ahead, ATS Bergamo is focused on enhancing communication with citizens, utilizing clearer messaging and expanded channels to promote screening participation and encourage healthy lifestyles. The agency will continue its commitment to monitoring, evaluation, and continuous improvement, guided by National and Regional Prevention Plans.
